Skip to content

Minerva Neurosciences, Inc.

NERV

CIK 0001598646

← back to feed
Revenue (TTM)
$0
Q1 Apr 2026
Net Income (TTM)
−$135.16M
−20,492.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$4.15
−18,347.4% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$15.73M
Q1 Apr 2026
Cash
$32.66M
Q1 Apr 2026
Total Debt
$9.39M
Q1 Apr 2026
Shares Outstanding
46.59M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings